miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors

miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors

Despite all the progress in treating SARS-CoV-2, escape mutants to current therapies remain a constant concern. Promising alternative treatments for current and future coronaviruses are those that limit escape mutants by inhibiting multiple pathogenic targets, analogous to the current strategies for...

Full description

Saved in:
Bibliographic Details
Main Authors: Parrish Evers, Spencer M. Uguccioni, Nadine Ahmed, Magen E. Francis, Alyson A. Kelvin, John P. Pezacki
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Viruses
Subjects:
SARS-CoV-2
COVID-19
microRNA
miR-24
miR-24-3p
HCoV-229E
Online Access:https://www.mdpi.com/1999-4915/16/12/1844
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items